| 30281509 |
Kirby Schwartzbauer |
2026-08-03 17:47:23.115
|
MLN Connects Special Edition: 3 Final Payment Rules - August 3, 2026 |
| 30281521 |
Kirby Schwartzbauer |
2026-08-03 17:47:25.7
|
MLN Connects Special Edition: 3 Final Payment Rules - August 3, 2026 |
| 30281915 |
Kirby Schwartzbauer |
2026-08-04 19:54:41.471
|
ICD-10 Diagnosis Coding Specificity Requirements |
| 30284352 |
James Marko |
2026-08-06 12:37:18.313
|
Billing and Coding: Electrocardiograms (A57326) - R12 - Effective October 1, 2023 |
| 30281443 |
Kirby Schwartzbauer |
2026-08-03 15:44:17.301
|
Clinical Diagnostic Laboratories: Act Now Before Reporting Period Ends |
| 30284587 |
James Marko |
2026-08-06 13:32:08.199
|
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R36 - Effective August 6, 2026 |
| 30284792 |
James Marko |
2026-08-06 14:30:10.018
|
Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection (A60155) - R1 - Effective August 30, 2026 |
| 30281903 |
Kirby Schwartzbauer |
2026-08-04 19:54:38.127
|
ICD-10 Diagnosis Coding Specificity Requirements |
| 30284604 |
James Marko |
2026-08-06 13:32:14.555
|
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R36 - Effective August 6, 2026 |
| 30284809 |
James Marko |
2026-08-06 14:30:15.886
|
Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection (A60155) - R1 - Effective August 30, 2026 |
| 30284909 |
Kirby Schwartzbauer |
2026-08-06 14:46:53.668
|
MLN Connects - August 6, 2026 |
| 30284921 |
Kirby Schwartzbauer |
2026-08-06 14:46:56.566
|
MLN Connects - August 6, 2026 |
| 30284723 |
James Marko |
2026-08-06 13:42:35.005
|
Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58679) - R12 - Effective August 6, 2026 |
| 30284335 |
James Marko |
2026-08-06 12:37:12.459
|
Billing and Coding: Electrocardiograms (A57326) - R12 - Effective October 1, 2023 |
| 30284672 |
James Marko |
2026-08-06 13:37:40.377
|
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R19 - Effective April 6, 2026 |
| 30284740 |
James Marko |
2026-08-06 13:42:40.46
|
Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58679) - R12 - Effective August 6, 2026 |
| 30281326 |
Kirby Schwartzbauer |
2026-08-03 15:36:14.728
|
Clinical Diagnostic Laboratories: Act Now Before Reporting Period Ends |
| 30284655 |
James Marko |
2026-08-06 13:37:35.354
|
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R19 - Effective April 6, 2026 |
